McKesson Corporation Acquires Controlling Interest in Core Ventures

June 3, 2025

McKesson Corporation completed the acquisition of an approximate 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for about $2.49 billion. The venture was established by Florida Cancer Specialists & Research Institute (FCS), whose physicians retained an approximate 30% interest; FCS remains independently owned and joins McKesson's The US Oncology Network to strengthen community-based oncology care and expand access to clinical development and local cancer services.

Buyers
McKesson Corporation
Targets
Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures)
Sellers
Florida Cancer Specialists & Research Institute (FCS) / FCS physicians
Location
Florida, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.